To the Editor: Parsa et al. 1 used Mendelian randomization to test the causal association between serum uric acid (SUA) and blood pressure. They found that decreases in SUA concentration due to a missense single-nucleotide polymorphism in the GLUT9 gene are directly associated with a lower level of blood pressure and concluded that SUA is causally associated with blood pressure. However, in the association analysis of SUA and blood pressure, only age and gender were adjusted. We are wondering whether the association between SUA and blood pressure remains significant upon further adjustment for other important covariates. Actually, a previous study has shown that the relationship between SUA and blood pressure was attenuated by up to 50% upon further adjustment for body mass index, waist-hip ratio, or body fat percent. 2 A recent meta-analysis has found a modest but significantly increased relative risk for incident hypertension in subjects with hyperuricemia, independent of traditional risk factors for hypertension. 3 However, adjusting for measures of insulin resistance could bias the effect estimates toward the null. 3 In our cross-sectional study including 4387 subjects randomly selected from a general population, SUA was significantly associated with systolic and diastolic blood pressures adjusting for gender and age, but the association was no longer significant after the further adjustment of body mass index and waist-hip ratio (Table 1) . If the association between SUA and blood pressure is no longer significant after complete adjustment, then the causal association might not be proved even with the use of Mendelian randomization. The Authors Reply: We fully appreciate the concern raised by Zhang et al. 1 regarding the unadjusted association between serum uric acid (SUA) and blood pressure. Indeed, this was the reason for our performing the Mendelian randomization (MR) analysis. 2 MR is based on the tenet that genotype, which is randomly assigned during gamete formation and fixed, cannot be modified by any of the traditional risk factors (e.g., obesity and diabetes) that occur after conception and hence is not confounded by them. 3 It is critical for the reader to be cognizant of this premise and, moreover, recognize that our analysis looked at the environmentally unconfounded and unidirectional association between GLUT9 genotype and blood pressure, as opposed to the easily confoundable association between SUA and blood pressure. 2 Indeed, as proof of concept, we showed in Table 2 of our original article that SUA was strongly associated with glucose, renal function, and body mass index (P values of 2.5 Â 10 À8 , 1.4 Â 10 À14 , and 1.5 Â 10
À31
, respectively), while, as expected, the GLUT9 genotype was not associated with these factors. 2 Conferring with the premise of MR and the complete lack of association between GLUT9 genotype and glucose, obesity, dyslipidemia, and renal function, we suitably did not adjust for them in our analysis. 2 We refer Zhang et al. 1 and the interested reader to a few of many reviews, for further details on how the use of MR in the appropriate setting can allow for reliable causal inferences, 3, 4 as in the case of SUA and blood pressure. Recently, we measured several biomarkers (glomerular, tubular, and inflammatory) in urine samples (stored for 0.7 years at À80 1C) of 102 ADPKD patients and found in a crosssectional study significant associations between several urinary biomarkers, including NGAL, and measures of ADPKD severity. 2 After having read the publication by Parikh et al, we investigated the association of these markers with decline in eGFR (Chronic Kidney Disease Epidemiology Collaboration) in patients whose follow-up data were available without experimental intervention (N ¼ 46, age 40±14 years, 48% male, baseline eGFR 73±37 ml/min per 1.73 m 2 , eGFR change during 2.6 years follow-up: À2.6 ± 3.2 ml/min per 1.73 m 2 /year). We found significant inverse associations between baseline urinary biomarker excretion of albumin, IgG, KIM-1, and MCP-1 and change in eGFR during follow-up (Table 1) . These associations remained significant after adjustment for age, gender, and baseline eGFR. Similar to Parikh et al, we found no significant association between NGAL and change in eGFR, neither crude (P ¼ 0.07) nor adjusted for age, sex, and baseline eGFR (P ¼ 0.47). Urinary IL-18 was not measured.
Importantly, we have previously shown that frozen storage decreases the measured concentration of urinary biomarkers, such as NGAL, and induces more variability, especially after longer storage. 3 The decline or increased variability in marker concentration that is induced by frozen storage can therefore reduce the association that, in reality, is present. We have shown this latter phenomenon for urinary albumin concentration in non-ADPKD subjects. 4 Given these findings, we caution against a too skeptical view toward the utility of urinary biomarkers to predict disease progression in ADPKD. Our data indicate that some of these markers may be useful. More research investigating their prognostic value in ADPKD is definitely needed.
Reappraisal of melamine exposure and adult calcium urolithiasis To the Editor: In reference to Lopez and Quereda's comments to our recent article and questions about source of low-dose melamine exposure and change in incidence in urolithiasis in adults in Taiwan, 1,2 since the melamine-tainted formula incident in China in 2008, melamine has been detected in a few daily food products such as eggs, wheat gluten, and meats. Our recent study found that some melamine could migrate from daily-used melamine-made tableware even at room 
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